Sanara Ventures is a healthcare investment platform, launched in 2015, as a joint venture between Philips Healthcare and Teva Pharmaceuticals and in collaboration with the Israeli Innovation Authority.

Providing financial and strategic support to seed through B-round staged innovators in digital health, medical devices and bio-convergence, Sanara Ventures supports companies transforming the way healthcare is delivered and received.

Through its access to the global leadership of Philips and Teva, Sanara Ventures offers portfolio companies unparalleled growth potential through access to product design expertise, global distribution systems and healthcare delivery processes.

Leveraging its international advisory board of 100+ world renowned experts, Sanara Ventures provides portfolio companies international reach and synergistic opportunities.

Its portfolio includes 14 active companies.